Bank of New York Mellon’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $29.2M | Sell |
|
|||||
2025
Q1 | $27.2M | Buy |
|
|||||
2024
Q4 | $26.5M | Buy |
|
|||||
2024
Q3 | $27.4M | Buy |
|
|||||
2024
Q2 | $29.5M | Buy |
|
|||||
2024
Q1 | $22.9M | Sell |
|
|||||
2023
Q4 | $24M | Sell |
|
|||||
2023
Q3 | $13.4M | Buy |
|
|||||
2023
Q2 | $16.6M | Sell |
|
|||||
2023
Q1 | $11.9M | Buy |
|
|||||
2022
Q4 | $11.5M | Buy |
|
|||||
2022
Q3 | $17.1M | Buy |
|
|||||
2022
Q2 | $12.1M | Sell |
|
|||||
2022
Q1 | $15.8M | Sell |
|
|||||
2021
Q4 | $68.9M | Sell |
|
|||||
2021
Q3 | $70.6M | Sell |
|
|||||
2021
Q2 | $61.2M | Buy |
|
|||||
2021
Q1 | $65.3M | Buy |
|
|||||
2020
Q4 | $56.4M | Buy |
|
|||||
2020
Q3 | $43.7M | Buy |
|
|||||
2020
Q2 | $35.3M | Buy |
|
|||||
2020
Q1 | $19.9M | Buy |
|
|||||
2019
Q4 | $16.9M | Buy |
|
|||||
2019
Q3 | $15.3M | Sell |
|
|||||
2019
Q2 | $20.1M | Buy |
|
|||||
2019
Q1 | $15.5M | Buy |
|
|||||
2018
Q4 | $9.82M | Sell |
|
|||||
2018
Q3 | $15M | Buy |
|
|||||
2018
Q2 | $12.2M | Sell |
|
|||||
2018
Q1 | $18.8M | Buy |
|
|||||
2017
Q4 | $14.6M | Buy |
|
|||||
2017
Q3 | $12.3M | Buy |
|
|||||
2017
Q2 | $8.85M | Buy |
|
|||||
2017
Q1 | $4.82M | Buy |
|
|||||
2016
Q4 | $2.62M | Buy |
|
|||||
2016
Q3 | $2.55M | Buy |
|
|||||
2016
Q2 | $1.43M | Buy |
|
|||||
2016
Q1 | $857K | Buy |
|
|||||
2015
Q4 | $1.06M | Buy |
|
|||||
2015
Q3 | $587K | Sell |
|
|||||
2015
Q2 | $874K | Buy |
|